Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
EditorialEditorial

The Impact Triad (Severity, Importance, Self-management) as a Method of Enhancing Measurement of Personal Life Impact of Rheumatic Diseases

TESSA C. SANDERSON, SARAH E. HEWLETT, CAROLINE FLUREY, EMMA DURES, PAMELA RICHARDS and JOHN R. KIRWAN
The Journal of Rheumatology February 2011, 38 (2) 191-194; DOI: https://doi.org/10.3899/jrheum.100700
TESSA C. SANDERSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SARAH E. HEWLETT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Sarah.Hewlett@uwe.ac.uk
CAROLINE FLUREY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EMMA DURES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAMELA RICHARDS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOHN R. KIRWAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Kalyoncu U,
    2. Dougados M,
    3. Daures J,
    4. Gossec L
    . Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis 2009;68:183–90.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Food and Drug Administration
    . Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labelling claims. 18 December 2009, UCM 193282. [Internet. Accessed September 27, 2010.] Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf
  3. 3.↵
    1. Hewlett S
    . Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol 2003;30:877–9.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Hewlett S,
    2. Sanderson T,
    3. May J,
    4. O’Bingham C,
    5. March L,
    6. Alten R,
    7. et al.
    “Just shoot me”: RA patients experience flare as more than painful, swollen joints [abstract]. Rheumatology 2010;49 Suppl 1:i141.
    OpenUrlCrossRef
  5. 5.↵
    1. Sanderson T,
    2. Morris M,
    3. Calnan M,
    4. Richards P,
    5. Hewlett S
    . Patient perspective of measuring treatment efficacy: the Rheumatoid Arthritis Patient Priorities for Pharmacological Interventions (RAPP-PI) outcomes. Arthritis Care Res 2010;62:647–56.
    OpenUrlCrossRef
  6. 6.↵
    1. Nicklin J,
    2. Cramp F,
    3. Kirwan J,
    4. Greenwood R,
    5. Urban M,
    6. Hewlett S
    . Measuring fatigue in RA: A cross sectional study to evaluate the Bristol RA Fatigue Multi-Dimensional Questionnaire, Visual Analogue and Numerical Rating Scales (BRAF). Arthritis Care Res 2010 Jun 25. Epub ahead of print
  7. 7.↵
    1. Gately C,
    2. Rogers A,
    3. Sanders C
    . Re-thinking the relationship between long-term condition self-management education and the utilisation of health services. Soc Sci Med 2007;65:934–45.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Department of Health
    . National service framework for long-term conditions. London: Department of Health; 2005.
  9. 9.↵
    1. Kralik D,
    2. Koch T,
    3. Price K,
    4. Howard N
    . Patient involvement in clinical nursing, J Clin Nurs 2004;13:259–67.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. van der Heijde D,
    2. Hof M,
    3. Piet L,
    4. Putte L
    . Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 1993;20:579–81.
    OpenUrlPubMed
  11. 11.↵
    1. Gossec L,
    2. Dougados M,
    3. Rincheval N,
    4. Balanescu A,
    5. Boumpas DT,
    6. Canadelo S,
    7. et al.
    The elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: A EULAR initiative. Ann Rheum Dis 2009;36:2097–9.
    OpenUrl
  12. 12.↵
    1. Tugwell P,
    2. Bombardier C,
    3. Buchanan WW,
    4. Goldsmith CH,
    5. Grace E,
    6. Hanna B
    . The MACTAR Patient Preference Disability Questionnaire: An individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 1987;14:446–51.
    OpenUrlPubMed
  13. 13.↵
    1. O’Boyle CA,
    2. McGee H,
    3. Hickey A,
    4. Joyce CRB,
    5. Browne J,
    6. O’Malley K,
    7. et al.
    The schedule for evaluation of individual quality of life. User manual. Dublin: Department of Psychology, Royal College of Surgeons in Ireland; 1993.
  14. 14.↵
    1. Hewlett S,
    2. Smith AP,
    3. Kirwan JR
    . Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ). Ann Rheum Dis 2002;61:986–93.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Verhoeven AC,
    2. Boers M,
    3. van der Liden S
    . Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. J Rheumatol 2000;27:2801–9.
    OpenUrlPubMed
  16. 16.↵
    1. Seror R,
    2. Tubach F,
    3. Baron G,
    4. Guillemin F,
    5. Ravaud P
    . Measure of function in rheumatoid arthritis: individualised or classical scales? Ann Rheum Dis 2010;69:97–101.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. ten Klooster PM,
    2. Taal E,
    3. Veehof MM,
    4. vand de Laar AFJ
    . Changes in priorities for health status improvement in patients with rheumatoid arthritis after TNF-blocking treatment [abstract]. Arthritis Rheum 2006;54 Suppl:S768.
    OpenUrl
  18. 18.↵
    1. Hewlett S,
    2. Cockshott Z,
    3. Kirwan J,
    4. Barrett J,
    5. Stamp J,
    6. Haslock I
    . Development and validation of a self-efficacy scale for use in British patients with rheumatoid arthritis (RASE). Rheumatology 2001;40:1221–30.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Ahmed S,
    2. Mayo NE,
    3. Wood-Dauphinee S,
    4. Hanley JA,
    5. Cohen SR
    . Response shift influenced estimates of change in health-related quality of life poststroke. J Clin Epidemiol 2004;57:561–70.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Ring L,
    2. Hofer S,
    3. Heuston F,
    4. Harris D,
    5. O’Boyle CA
    . Response shift masks the treatment impact on patient reported outcomes (PROs): The example of individual quality of life in edentulous patients. Health Qual Life Outcomes 2005;3:55.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 38, Issue 2
1 Feb 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Impact Triad (Severity, Importance, Self-management) as a Method of Enhancing Measurement of Personal Life Impact of Rheumatic Diseases
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Impact Triad (Severity, Importance, Self-management) as a Method of Enhancing Measurement of Personal Life Impact of Rheumatic Diseases
TESSA C. SANDERSON, SARAH E. HEWLETT, CAROLINE FLUREY, EMMA DURES, PAMELA RICHARDS, JOHN R. KIRWAN
The Journal of Rheumatology Feb 2011, 38 (2) 191-194; DOI: 10.3899/jrheum.100700

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
The Impact Triad (Severity, Importance, Self-management) as a Method of Enhancing Measurement of Personal Life Impact of Rheumatic Diseases
TESSA C. SANDERSON, SARAH E. HEWLETT, CAROLINE FLUREY, EMMA DURES, PAMELA RICHARDS, JOHN R. KIRWAN
The Journal of Rheumatology Feb 2011, 38 (2) 191-194; DOI: 10.3899/jrheum.100700
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Acknowledgment
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Microdissecting Epigenetic Pathways in Oligoarticular Juvenile Idiopathic Arthritis: A New Avenue in Transforming Growth Factor β?
  • Ro52, Myositis, and Interstitial Lung Disease
  • Sex Effect in Psoriatic Arthritis
Show more Editorial

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire